Methotrexate injections for psoriasis

Discontinuation of methotrexate in psoriasis.

Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference.

BACKGROUND Methotrexate remains a valuable option for the treatment of psoriasis. This report will summarize studies regarding the use of methotrexate since the last guidelines were published in 1998. OBJECTIVE A task force of the National Psoriasis Foundation Medical Board was convened to evaluate treatment options. Our aim was to achieve a consensus on new updated guidelines for the use of ...

Near fatal drug interactions with methotrexate given for psoriasis.

In this study children were more commonly exposed to pertussis by a sibling (22/26) than a parent, and 25 ofthe 26 children and adults responsible for transmitting the infection had typical disease. Atypical disease occurred in older children and parents but was almost exclusively associated with secondary rather than primary infection. Furthermore, isolation of B pertussis (which may reflect a...

Topical Methotrexate for Treatment of Psoriasis: Formulation and Clinical Implications

Background: To test effectiveness and safety of topical methotrexate 0.5%gel and to introduce new formula of methotrexate gel using suitable media for delivery. Patients and Methods: The clinical work was performed at the Department of Dermatology and Venereology in Baghdad Teaching Hospital during the period from January 2008 to October 2008. While preparation of formula was performed in the l...

Update on subcutaneous methotrexate for inflammatory arthritis and psoriasis

Methotrexate (MTX) is one of the mainstays of treatment for several immune-mediated inflammatory joint and skin diseases, especially rheumatoid arthritis (RA) and moderate-to-severe psoriasis. Oral MTX has been used for the treatment of such diseases for decades for many reasons. There is, however, a relevant interpatient variability of clinical and safety outcomes that can also be related to d...